Sprott Q3 Net Income, Revenue Rise-February 2024-www.financetom.com

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sprott Q3 Net Income, Revenue Rise

Nov 5, 2025 5:38 AM

08:23 AM EST, 11/05/2025 (MT Newswires) -- Sprott (SII) reported Q3 net income Wednesday of $0.51 per share, up from $0.50 a year earlier.

Three analysts polled by FactSet expected $0.66.

Net revenue for the quarter ended Sept. 30 was $49.2 million, up from $37.1 million a year earlier.

Two analysts surveyed by FactSet expected $50.7 million.

Previous page： Market Chatter: CNN, NBC News Plan Staff Reductions This Week Next page： Analysis-Britain appeals to Big Tech with change of regulatory guard

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: CNN, NBC News Plan Staff Reductions This Week

Jan 23, 2025

07:55 AM EST, 01/23/2025 (MT Newswires) -- Warner Bros. Discovery's ( WBD ) CNN plans to cut hundreds of jobs as part of its strategy to shift to a global digital audience, CNBC reported Thursday, citing people familiar with the matter. The layoffs will help CNN to reduce production costs and consolidate teams, the sources said and added that shows...

Analysis-Britain appeals to Big Tech with change of regulatory guard

Jan 23, 2025

LONDON (Reuters) - Britain's choice of a former Amazon executive to chair its antitrust regulator is a clear pitch for investment, including from Big Tech, and signals it is prepared to go easier on deal-making if that would help, company bosses and lawyers said. Doug Gurr, former boss of the U.S. online retailer's UK operation, was picked to chair the...

Biogen Gets FDA, EMA Approval to Study Higher Dose Regimen of Spinal Muscular Atrophy Treatment

Jan 23, 2025

07:55 AM EST, 01/23/2025 (MT Newswires) -- Biogen (BIIB) announced Thursday that the US Food and Drug Administration has accepted its supplemental new drug application and that the European Medicines Agency has validated the application for a higher dose regimen of its experimental drug, nusinersen, for spinal muscular atrophy. The company said it would study the efficacy of a higher...

Troilus Gold Makes Leadership Appointments as Project Development Advances

Jan 23, 2025

07:59 AM EST, 01/23/2025 (MT Newswires) -- Troilus Gold ( CHXMF ) said Thursday that it expanded its engineering team with three appointments as it continues to advance the Troilus project in Quebec. The company appointed Denis Rivard as executive vice president of projects and named Chris Sharpe vice president of technical services, effective Feb. 1. Troilus Gold ( CHXMF...